Neratinib (Nerlynx®) Diarrhea Management

To promote higher quality patient care, NCODA created the Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance document for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, each PQI equips the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI discusses the prevention/treatment of diarrhea, a major side effect of neratinib. The article, which expands on the Neratinib (NERLYNX®) Diarrhea Management PQI, explores how the medically integrated teams at Cancer Care Associates of York and Rocky Mountain Cancer Centers incorporate PQIs as part of their daily workflow and how the Neratinib (NERLYNX®) Diarrhea Management PQI elevates patient care.